Adverse Event Clinical Research R4 Backport
1.0.1 - STU1 International flag

This page is part of the Adverse Event Clinical Research R4 Backport (v1.0.1: STU 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

: medication-administration-kadcyla - JSON Representation

Page standards status: Informative

Raw json | Download


{
  "resourceType" : "MedicationAdministration",
  "id" : "medication-administration-kadcyla",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: MedicationAdministration</b><a name=\"medication-administration-kadcyla\"> </a><a name=\"hcmedication-administration-kadcyla\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource MedicationAdministration &quot;medication-administration-kadcyla&quot; </p></div><p><b>status</b>: completed</p><p><b>medication</b>: KADCYLA <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-v3-rxNorm.html\">RxNorm</a>#1371046)</span></p><p><b>subject</b>: <a href=\"Patient-patient-example-kaitlyn-b.html\">Patient/patient-example-kaitlyn-b</a> &quot; BOUNCE&quot;</p><p><b>effective</b>: 2020-04-01</p><h3>Performers</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Actor</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"Practitioner-practitioner-oncology-nurse-jane.html\">Practitioner/practitioner-oncology-nurse-jane</a> &quot; NURSE&quot;</td></tr></table><p><b>request</b>: <a href=\"MedicationRequest-medication-request-example-kadcyla.html\">MedicationRequest/medication-request-example-kadcyla</a></p><p><b>note</b>: 3.6mg administered by continuous infusion. Patient tolerated infusion without side effects. (By Practitioner/practitioner-oncology-nurse-jane @2020-04-01)</p><h3>Dosages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Route</b></td><td><b>Dose</b></td></tr><tr><td style=\"display: none\">*</td><td>Intravenous route (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#47625008)</span></td><td>3.6 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span></td></tr></table></div>"
  },
  "status" : "completed",
  "medicationCodeableConcept" : {
    "coding" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "code" : "1371046",
        "display" : "KADCYLA"
      }
    ]
  },
  "subject" : {
    🔗 "reference" : "Patient/patient-example-kaitlyn-b"
  },
  "effectiveDateTime" : "2020-04-01",
  "performer" : [
    {
      "actor" : {
        🔗 "reference" : "Practitioner/practitioner-oncology-nurse-jane"
      }
    }
  ],
  "request" : {
    🔗 "reference" : "MedicationRequest/medication-request-example-kadcyla"
  },
  "note" : [
    {
      "authorReference" : {
        🔗 "reference" : "Practitioner/practitioner-oncology-nurse-jane"
      },
      "time" : "2020-04-01",
      "text" : "3.6mg administered by continuous infusion. Patient tolerated infusion without side effects."
    }
  ],
  "dosage" : {
    "route" : {
      "coding" : [
        {
          "system" : "http://snomed.info/sct",
          "code" : "47625008",
          "display" : "Intravenous route (qualifier value)"
        }
      ]
    },
    "dose" : {
      "value" : 3.6,
      "unit" : "mg",
      "system" : "http://unitsofmeasure.org",
      "code" : "mg"
    }
  }
}